Last reviewed · How we verify

NCT03713112

Efficacy and Feasibility of De-prescribing Rounds in a Singapore Rehabilitative Hospital- a Pilot Randomized Controlled Trial

Status unknown NA Last updated 20 May 2020
What this trial tests

NA trial testing Weekly MDT deprescribing rounds for certain drugs in Deprescribing in 260 participants. Status unknown.

Timeline
28 November 2018
Primary endpoint
31 July 2019
30 June 2020

Quick facts

Lead sponsorBright Vision Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment260
Start date28 November 2018
Primary completion31 July 2019
Estimated completion30 June 2020
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

Bright Vision Hospital

Who can join

Adults 65 to 120, any sex, with Deprescribing or Multi-disciplinary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This open-labelled randomized control trial will be conducted in a Singapore Rehabilitation Hospital to investigate the efficacy, cost-reduction, safety and feasibility of a weekly deprescribing multi-disciplinary inpatient deprescribing round up to 28 days post discharge.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Medication review in hospitalised patients to reduce morbidity and mortality.
    Bülow C, Clausen SS, Lundh A, Christensen M. · · 2023 · cited 37× · PMID 36688482 · DOI 10.1002/14651858.cd008986.pub4
  2. Feasibility & Efficacy of Deprescribing rounds in a Singapore rehabilitative hospital- a randomised controlled trial.
    Wong APY, Ting TW, Charissa EJM, Boon TW, et al · · 2021 · cited 9× · PMID 34674645 · DOI 10.1186/s12877-021-02507-0

Verify or expand the search:

Other recruiting trials for Deprescribing

Currently open trials in the same condition.

Other Bright Vision Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03713112.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing